Anthrax Research Today is a free monthly online journal that collates and summarizes the latest research about Anthrax, including details on bacillus anthracis, contagiousness, exposure, effects.

Volume 4 (2008), Issue 4 (April)

1. COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro.
   Proc Natl Acad Sci U S A, 105(13): 5254-9. [Abstract] [Full-text]
2. Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.
   Bioorg Med Chem Lett, 18(7): 2467-70. [Abstract] [Full-text]
3. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
   J Immunol Methods, 333(1): 89-106. [Abstract] [Full-text]
4. Detoxified lethal toxin as a potential mucosal vaccine against anthrax.
   Clin Vaccine Immunol, 15(4): 612-6. [Abstract] [Full-text]
5. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
   J Biol Chem, 283(15): 9531-42. [Abstract] [Full-text]
6. The conserved PA14 domain of cell wall-associated fungal adhesins governs their glycan-binding specificity.
   Mol Microbiol, 68(3): 535-7. [Abstract] [Full-text]
7. Rapid point-of-care test to detect broad ranges of protective antigen-specific immunoglobulin G concentrations in recipients of the U.S.-licensed anthrax vaccine.
   Clin Vaccine Immunol, 15(4): 644-9. [Abstract] [Full-text]
8. Bioterrorism: class a agents and their potential presentations in immunocompromised patients.
   Clin J Oncol Nurs, 12(2): 295-302. [Abstract] [Full-text]
9. Infectious agents of bioterrorism: a review for emergency physicians.
   Emerg Med Clin North Am, 26(2): 517-47. [Abstract] [Full-text]
10. Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxin.
    Cell Microbiol, 10(5): 1190-207. [Abstract] [Full-text]
11. High resolution genotyping of Bacillus anthracis outbreak strains using four highly mutable single nucleotide repeat markers.
    Lett Appl Microbiol, 46(5): 600-3. [Abstract] [Full-text]
12. High-level expression and single-step purification of recombinant Bacillus anthracis protective antigen from Escherichia coli.
    Biotechnol Appl Biochem. [Abstract] [Full-text]
13. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant.
    Infect Immun, 76(5): 1952-9. [Abstract] [Full-text]
14. Renewable enzyme reactors based on beds of artificial gel antibodies.
    J Biochem Biophys Methods, 70(6): 1188-91. [Abstract] [Full-text]
15. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.
    Cell, 133(2): 235-49. [Abstract] [Full-text]
16. Real time detection of anthrax spores using highly specific anti-EA1 recombinant antibodies produced by competitive panning.
    J Immunol Methods, 334(1): 1-10. [Abstract] [Full-text]
17. Liberty to Decide on Dual Use Biomedical Research: An Acknowledged Necessity.
    Sci Eng Ethics. [Abstract] [Full-text]
18. Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus.
    Proc Natl Acad Sci U S A, 105(16): 6150-5. [Abstract] [Full-text]
19. The Bacillus cereus containing sub-branch most closely related to Bacillus anthracis, have single amino acid substitutions in small acid-soluble proteins, while remaining sub-branches are more variable.
    Mol Cell Probes, 22(3): 207-11. [Abstract] [Full-text]
20. Molecular epidemiology of Bacillus anthracis: determining the correct origin.
    Appl Environ Microbiol, 74(9): 2928-31. [Abstract] [Full-text]
21. Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loops.
    J Mol Biol, 378(5): 1094-103. [Abstract] [Full-text]

© 2005-2008 Anthrax Research Today. All Rights Reserved.